How to Read an Injectable's Instructions for Use

The box arrives, the lot is checked, the product goes into the drawer, and the instructions for use stay inside the packaging, folded, never opened again. It is a common habit, and it is a mistake. The instructions for use are the document that says, in regulatory language, what the product was approved for, where it should not be used, and what the manufacturer already knows can go wrong.

This page shows how to read the instructions of an injectable (filler, toxin, biostimulator) with a clinical eye, at review level. It does not summarize any specific product, does not name brands, and does not replace the document that comes with your lot.

Why do the instructions for use matter so much?

There are three practical reasons:

1. Safety: warnings and contraindications describe situations in which the risk is higher, often learned from real adverse events.
2. Compliance: the approved indication is part of the product's regulatory registration. Using the product outside it is possible in some contexts, but it increases the professional's responsibility.
3. Defense: in case of a complaint, a patient record showing that you knew the instructions and made a justified decision carries far more weight than the memory of a course.

The first step is to confirm that the product exists in the registry. See how to check an injectable's registration with ANVISA and the glossary entry on regulatory registration.

In what order should you read the document?

There is no mandatory order, but this one works well for someone short on time who needs to decide about the product:

Read with a pen in hand or a digital highlighter. Underline what differs from your practice, and take those differences to your next conversation with the supplier or the technical manager.

What does the indication section reveal?

The indication describes the use for which the product was studied and approved: type of correction, area, and, often, the patient profile. It is the section that defines what counts as "on-label" and "off-label" use.

Off-label use is not forbidden in itself, but it changes the tone of the relationship with the patient. In general, it requires:

• clinical justification for the choice;
• a specific conversation with the patient, so they understand the use differs from the approved one;
• documentation in the patient record and the consent form;
• compliance with what your professional board determines on the subject.

Contraindications and warnings: what is the difference?

The distinction is simple and important:

Conditions such as known allergy to components, active infection in the area, pregnancy and breastfeeding (when there are no data), autoimmune diseases, and use of certain drugs usually appear in these sections. They connect with your medical history in HOF and with the general contraindications in HOF. If something in the patient's history appears on the list, the reasoning is to stop, assess, and decide with documentation, not to go ahead out of habit.

Adverse events: how do you interpret the list?

The adverse event list mixes the frequent and the serious, the transient and the permanent. Read it in three layers:

1. Common and expected, such as swelling, pain, redness, and bruising. They feed the aftercare instructions.
2. Uncommon but relevant, such as nodules and asymmetry. They feed the consent form.
3. Serious and rare, such as vascular occlusion and visual complications. They feed the emergency kit and the response protocol.

The instructions are not a list of exact probabilities, but they are the minimum the patient should hear from you. To organize the conversation, see communicating risk to the patient and explaining the risks of each procedure to the patient. When the product is hyaluronic acid, also remember hyaluronidase in the clinic, which must be available.

What should you read about storage, expiration, and traceability?

It is the section most often lost in the routine and the one that causes the most silent problems. Look for:

• the storage temperature range and whether a cold chain exists (see cold chain);
• protection from light and from freezing;
• time limit for use after opening or reconstitution, for products where it applies;
• disposal instructions for the product and for sharps;
• what must be stuck in or noted in the patient record (lot, expiration date, quantity, site).

These items connect with injectable inventory control, traceability of injectables, and the glossary entry on expiration date.

How do you apply the reading in the daily life of the clinic?

Reading once and forgetting does not solve anything. It is worth creating simple routines:

• When you switch product or presentation, reread the full instructions and note the differences from what you were using.
• When you add a new area to your menu of services, check whether it is in the indication. If it is not, follow the off-label path, with documentation.
• In team meetings, pick one section per month to review aloud, with real cases.
• In the consent form, align the warnings with what the manufacturer describes, without copying the technical text unexplained.

Where does Harmy come into this conversation?

The app does not replace the instructions for use: it works in the conversation with the patient, showing in an illustrative projection, from a frontal photo, how marked areas could look with a volume in ml. It is an illustrative simulation, not a promise of results. What will be used, in what amount, and with what technique remains a decision for the qualified professional, based on clinical assessment and the product's instructions.